These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32090746)

  • 21. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
    Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyunsaturated fatty acids and inflammatory markers in major depressive episodes during pregnancy.
    Chang JP; Lin CY; Lin PY; Shih YH; Chiu TH; Ho M; Yang HT; Huang SY; Gałecki P; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):273-278. PubMed ID: 28536068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
    Su KP; Huang SY; Chiu TH; Huang KC; Huang CL; Chang HC; Pariante CM
    J Clin Psychiatry; 2008 Apr; 69(4):644-51. PubMed ID: 18370571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus statements on the clinical understanding and use of bupropion in Hong Kong.
    Lee WK; Au Yeung KL; Lam HB; Wong CK; Wong TC; Fu CK; Sham SK; Au MK; Lam TC; Ki-Yan Mak D
    CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):20-24. PubMed ID: 33555615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-disciplinary supportive end of life care in long-term care: an integrative approach to improving end of life.
    Harasym PM; Afzaal M; Brisbin S; Sinnarajah A; Venturato L; Quail P; Kaasalainen S; Straus S; Sussman T; Virk N; Holroyd-Leduc JM
    BMC Geriatr; 2021 May; 21(1):326. PubMed ID: 34022818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Bipolar Disorder: A Review of Biomarker and Treatment Studies.
    Saunders EF; Ramsden CE; Sherazy MS; Gelenberg AJ; Davis JM; Rapoport SI
    J Clin Psychiatry; 2016 Oct; 77(10):e1301-e1308. PubMed ID: 27631140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Psychoneuroimmunological Role of Omega-3 Polyunsaturated Fatty Acids in Major Depressive Disorder and Bipolar Disorder.
    Rutkofsky IH; Khan AS; Sahito S; Kumar V
    Adv Mind Body Med; 2017 Summer; 31(3):8-16. PubMed ID: 28987035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression.
    Su KP
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():151-7. PubMed ID: 18296325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Delphi survey to determine how educational interventions for evidence-based practice should be reported: stage 2 of the development of a reporting guideline.
    Phillips AC; Lewis LK; McEvoy MP; Galipeau J; Glasziou P; Hammick M; Moher D; Tilson JK; Williams MT
    BMC Med Educ; 2014 Jul; 14():159. PubMed ID: 25081371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pedi-R-MAPP: The development of a nutritional awareness tool for use in remote paediatric consultations using a modified Delphi consensus.
    Marino LV; Collaço NC; Ashton JJ; Cader S; Cooke ML; Cooke LH; Gerasimidis K; Guz-Mark A; Hulst JM; Vranesic Bender D; Huysentruyt K; Joosten K; Kolacek S; Krznaric Z; Meyer R; Nemet D; Niseteo T; Selimoglu MA; Shamir R; Darlington ASE; Beattie RM
    Clin Nutr; 2022 Mar; 41(3):661-672. PubMed ID: 35149245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders.
    Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
    Psychoneuroendocrinology; 2018 Jan; 87():53-62. PubMed ID: 29040890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
    Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
    PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Efficacy and Biological Regulations of ω-3 PUFA-Derived Endocannabinoids in Major Depressive Disorder.
    Yang B; Lin L; Bazinet RP; Chien YC; Chang JP; Satyanarayanan SK; Su H; Su KP
    Psychother Psychosom; 2019; 88(4):215-224. PubMed ID: 31269506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reply to "Letter regarding "Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial"".
    Chang JP; Su KP
    Brain Behav Immun; 2023 Oct; 113():317-318. PubMed ID: 37524215
    [No Abstract]   [Full Text] [Related]  

  • 35. Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder.
    Beier AM; Lauritzen L; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
    J Psychiatr Res; 2014 Oct; 57():133-40. PubMed ID: 25017608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omega 3 polyunsaturated fatty acids and the treatment of depression.
    Deacon G; Kettle C; Hayes D; Dennis C; Tucci J
    Crit Rev Food Sci Nutr; 2017 Jan; 57(1):212-223. PubMed ID: 25830700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
    Park Y; Park YS; Kim SH; Oh DH; Park YC
    Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An international Delphi study examining health promotion and health education in nursing practice, education and policy.
    Whitehead D
    J Clin Nurs; 2008 Apr; 17(7):891-900. PubMed ID: 18321288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega-3 Polyunsaturated Fatty Acids and Blood-Brain Barrier Integrity in Major Depressive Disorder: Restoring Balance for Neuroinflammation and Neuroprotection.
    Zailani H; Wang WL; Satyanarayanan SK; Chiu WC; Liu WC; Sung YS; Chang JP; Su KP
    Yale J Biol Med; 2024 Sep; 97(3):349-363. PubMed ID: 39351324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.
    Su KP; Huang SY; Chiu CC; Shen WW
    Eur Neuropsychopharmacol; 2003 Aug; 13(4):267-71. PubMed ID: 12888186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.